Frisch Stephanie, Askari Sharone K, Beaty Stacy Russel, Burkemper C Nicole
Department of Dermatology, Saint Louis University School of Medicine, Saint Louis, MO 63104, USA.
J Drugs Dermatol. 2010 May;9(5):562-4.
Due to the mutations in the nicotinamide dinucleotide phosphate (NADPH) oxidase complex in X-linked chronic granulomatous disease (CGD), the phagocytic activity in these patients is curtailed by a dysfunctional respiratory burst. This can lead to life-threatening bacterial and fungal infections. The prognosis for patients with CGD has dramatically improved with the advent of effective prophylactic drugs targeting catalase-positive bacteria, opportunistic Gram-negative bacteria and fungi. Voriconazole, a second-generation triazole, is a commonly used agent for prophylaxis in this population. The authors report a case of photoaging and photosensitivity reaction associated with voriconazole exposure in a 10-year-old boy with X-linked CGD. With broad-spectrum sunscreen, topical steroids, and discontinuation of voriconazole, the patient showed significant improvement.
由于X连锁慢性肉芽肿病(CGD)中烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶复合物发生突变,这些患者的吞噬活性因呼吸爆发功能障碍而受到限制。这可能导致危及生命的细菌和真菌感染。随着针对过氧化氢酶阳性细菌、机会性革兰氏阴性细菌和真菌的有效预防性药物的出现,CGD患者的预后有了显著改善。伏立康唑是第二代三唑类药物,是该人群常用的预防药物。作者报告了1例10岁患有X连锁CGD的男孩在使用伏立康唑后出现光老化和光敏反应的病例。通过使用广谱防晒霜、外用类固醇以及停用伏立康唑,患者病情有了显著改善。